https://www.selleckchem.com/pr....oducts/gsk3368715.ht
The efflux capacity is significantly increased in the presence of lipids compared to non-lipidated RG33. Finally, acute treatment with the RG33 peptide significantly improves the glucose clearance capacity of insulin resistant mice. The impact of the RG33 peptide on glucose control and cholesterol transport, as well as the physicochemical properties, makes it a good candidate for translational exploration of its therapeutic potential in diabetes treatment.The adaptation of a broad genomic sequencing approach in the clinical setting h
Curtir
Comentario
Compartilhar
